Riskpilot← Back to searchSign inGet full accessAbdomen AB
ABActiveOrg 5569384513Norra Spolegatan 4Business and other management consultancy activities · NACE 7020Est. 20132 employees
Revenue 2024
SEK 133
EBITDA margin
-307924.8%
-75% vs 2023
Equity ratio
89.7%
Financial strength
Net profit 2024
SEK 2K
+109% vs 2023
| Revenue | SEK 133 | — |
| EBITDA | SEK -410K | -75% |
| Net profit | SEK 2K | +109% |
| Total assets | SEK 1,1M | -7% |
| Equity | SEK 998K | -17% |
| Employees | 2 | — |
Legal name
Abdomen AB
Org number
5569384513
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
1 augusti 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva nedanstående och därmed förenlig verksamhet.Sjukvård och medicinsk konsultverksamhet. Äga och driva sjukvårdsinrättningar. Forskning och utbildning inom det medicinska området. Konsultverksamhet inom området planera och bygga sjukvårdsinrättningar.Äga och förvalta fast och lös egendom.
Address
Norra Spolegatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 665 | 183 | −17 | 0 | 0 |
| Staff expenses | — | — | −18 | −17 | −22 |
| EBITDA | 470 | −219 | −354 | −234 | −410 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 470 | −219 | −354 | −234 | −410 |
| Net financials | 11 | 468 | −129 | 67 | 412 |
| Profit before tax | 592 | 249 | 10 | −26 | 2 |
| Tax | −131 | −53 | −9 | — | — |
| Net profit | 461 | 196 | 1 | −26 | 2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 694 | 2 260 | 1 578 | 1 203 | 1 113 |
| Equity | 1 596 | 1 609 | 1 422 | 1 200 | 998 |
| Long-term debt | 1 | 2 | 3 | −18 | 37 |
| Short-term debt | 464 | 16 | 12 | 21 | 77 |
| Total debt | 465 | 18 | 16 | 3 | 115 |
EBITDA margin
-307924.8%
This company
15.8%
Market median
-1948991% vs market
20202024
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20202024
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20202024
Net profit margin
1821.1%
This company
8.1%
Market median
+22383% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CC Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abdomen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| C Christer S Staël von Holstein | Chief Executive Officer | 0 companies |
| Karin Staël von Holstein | Deputy Board Member | 0 companies |